Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, GoodRx Holdings Inc (NASDAQ: GDRX) closed at $4.16 down -2.58% from its previous closing price of $4.27. In other words, the price has decreased by -$2.58 from its previous closing price. On the day, 2.58 million shares were traded. GDRX stock price reached its highest trading level at $4.33 during the session, while it also had its lowest trading level at $4.16.
Ratios:
For a deeper understanding of GoodRx Holdings Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.63. For the most recent quarter (mrq), Quick Ratio is recorded 4.21 and its Current Ratio is at 4.21. In the meantime, Its Debt-to-Equity ratio is 0.85 whereas as Long-Term Debt/Eq ratio is at 0.84.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on August 09, 2024, while the target price for the stock was maintained at $10.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 05 ’25 when Spectrum Equity VII, L.P. sold 16,016 shares for $4.05 per share. The transaction valued at 64,865 led to the insider holds 0 shares of the business.
Spectrum VII Investment Manage bought 10,243 shares of GDRX for $40,972 on Sep 05 ’25. On Sep 05 ’25, another insider, Spectrum VII Co-Investment Fun, who serves as the Affiliate of the company, bought 5,773 shares for $4.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 1483611392 and an Enterprise Value of 1711612032. As of this moment, GoodRx’s Price-to-Earnings (P/E) ratio for their current fiscal year is 44.83, and their Forward P/E ratio for the next fiscal year is 9.19. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.96. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.81 while its Price-to-Book (P/B) ratio in mrq is 2.28. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is 12.715.
Stock Price History:
The Beta on a monthly basis for GDRX is 1.19, which has changed by -0.40229887 over the last 52 weeks, in comparison to a change of 0.1443547 over the same period for the S&P500. Over the past 52 weeks, GDRX has reached a high of $7.11, while it has fallen to a 52-week low of $3.31. The 50-Day Moving Average of the stock is -1.18%, while the 200-Day Moving Average is calculated to be -7.09%.
Shares Statistics:
For the past three months, GDRX has traded an average of 4.27M shares per day and 9344600 over the past ten days. A total of 99.90M shares are outstanding, with a floating share count of 81.47M. Insiders hold about 76.55% of the company’s shares, while institutions hold 15.75% stake in the company. Shares short for GDRX as of 1759190400 were 6269859 with a Short Ratio of 1.47, compared to 1756425600 on 6679799. Therefore, it implies a Short% of Shares Outstanding of 6269859 and a Short% of Float of 7.180000000000001.
Earnings Estimates
GoodRx Holdings Inc (GDRX) is presently subject to a detailed evaluation by 12.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.1, with high estimates of $0.11 and low estimates of $0.08.
Analysts are recommending an EPS of between $0.4 and $0.34 for the fiscal current year, implying an average EPS of $0.38. EPS for the following year is $0.46, with 12.0 analysts recommending between $0.51 and $0.39.
Revenue Estimates
A total of 13 analysts believe the company’s revenue will be $195.08M this quarter.It ranges from a high estimate of $202.61M to a low estimate of $192.54M. As of. The current estimate, GoodRx Holdings Inc’s year-ago sales were $195.25MFor the next quarter, 13 analysts are estimating revenue of $198.15M. There is a high estimate of $203.76M for the next quarter, whereas the lowest estimate is $194.1M.
A total of 15 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $812.41M, while the lowest revenue estimate was $794.01M, resulting in an average revenue estimate of $798.9M. In the same quarter a year ago, actual revenue was $792.32MBased on 15 analysts’ estimates, the company’s revenue will be $840.81M in the next fiscal year. The high estimate is $871.41M and the low estimate is $816.1M.